Drug Discovery

#AACR 2023 #Cancer research #Cancer vaccine #Drug discovery #Oncology

This week in drug discovery (16-21 April)

News round-up for 16-21 April by DDW Digital Content Editor Diana Spencer. The news stories dominating the headlines this week have been the breaking developments in cancer drug discovery announced at the American Association of Cancer Research (AACR) Annual Meeting, which was held in Florida, US… Read More

#News

#Antibiotics #Cancer vaccine #Drug discovery #HIV #Long Covid #Malaria

This week in drug discovery (10-14 April)

News round-up for 10-14 April by DDW Digital Content Editor Diana Spencer. The headlines getting our attention this week all represent significant breakthroughs in the treatment of various diseases and could make a huge difference to the lives of these patients. Perhaps most significantly,… Read More

#News

#Drug discovery #Fragment-based drug discovery #Liquid chromatography #Mass spectrometry / NMR #SCIEX

How a recent advancement in mass spectrometry supports drug discovery

This paid-for advertorial by SCIEX appeared in DDW Volume 24 – Issue 2, Spring 2023 Imagine having the ability to consistently identify metabolic soft spots from an experiment that uses liquid chromatography coupled to mass spectrometry (LC-MS), reducing the need for additional safety testing in the… Read More

#Exclusive Content

Antibody drug conjugate
#AI / data analytics / healthtech / informatics #Antibodies #Antibody drug conjugate (ADC) #Big pharma #Drug development #Precision medicine

A personal view on antibody drug development

Oliver Schon, PhD, is VP Research & Development at BiVictriX Therapeutics, a UK-based emerging drug discovery and development company generating a pioneering first-in-class next-generation ADC anti-cancer therapeutics which exhibit superior selectivity towards cancer. Dr Schon is applying his broad expertise from lead discovery to manufacture in order to progress differentiated,… Read More

#Exclusive Content

#Clinical trials #Drug discovery

The need for greater diversity in clinical trials  

By Lucy Radley, Senior Vice President, Head of European Regulatory Development at ProPharma Group.  Clinical trials are, undoubtedly, an essential part of the drug development process, providing us with valuable information about the safety and efficacy of new treatments and therapies. However, despite their deep importance to the wellbeing… Read More

#Exclusive Content

#Cancer research #Drug discovery #IRBM #Oncology #Rare cancers

Reshaping rare cancer drug discovery

This paid-for advertorial by IRBM appeared in DDW Volume 24 – Issue 2, Spring 2023 The landscape for treating rare cancers is changing with advances in molecular genetics, novel drug modalities and patient-derived models. Dr Alessandro Carugo, IRBM, explains how building unique drug discovery strategies and expert… Read More

#Exclusive Content

Organ on a chip
#CN Bio #Drug development #Drug screening #In vivo #Organ-on-a-chip #Organoids #SLAS

Organ-on-a-chip models in drug development

This paid-for advertorial by CN Bio appeared in DDW Volume 24 – Issue 2, Spring 2023 Despite advancements, the drug development process remains inefficient. Even with rigorous optimisation and validation, we face a 90% failure rate by the clinical phase1. Existing in vivo and in vitro models aren’t up to… Read More

#Exclusive Content

#Cell culture #Drug development #Drug discovery #Guide #iPSC

New Guide: How to get the best out of your neurons

A new Guide is now available entitled ‘Four cell culture hacks to get the best out of your neurons’, sponsored by bit.bio. Make your iPSC-derived glutamatergic neuron cultures a success every time with these tips from a neuronal cell culture expert. Download the Guide to learn: How to prevent glutamatergic… Read More

#News

#Cell culture #Drug development #Drug discovery #Guide #iPSC

Four cell culture hacks to get the best out of your neurons

Make your iPSC-derived glutamatergic neuron cultures a success every time with these tips from a neuronal cell culture expert. In this Guide, you will learn: How to prevent glutamatergic neurons from detaching from culture surfaces How to formulate extracellular matrix coatings to promote cell adherence The best timings for media… Read More

#Intelligence #Resources

#Antibodies #Drug discovery #Events #High throughput screening #Protein inhibitor

Symposium: Unlock high-throughput biology

The Carterra 2023 Symposia Series ‘Unlocking High-Throughput Biology and Drug Discovery’ is now open for registrations. Join industry-leading scientists from GSK, Oxford University, LifeArc, Alloy Therapeutics, Sanofi, and Carterra on April 19, 2023 in Cambridge, UK for this one-day, science-filled experience. Learn about the current advancements… Read More

#News

#Drug discovery #Immunotherapy #Oncology

Latest DDW Guide: Exclusive insight into cancer research

DDW has published the latest addition to its Guide Series, ‘Find out about the global breakthroughs, opportunities and developments in cancer research.’ It is sponsored by IRBM. In this free, exclusive guide, you will learn more about: Where the global breakthroughs, opportunities and developments are in cancer research Why cancer-associated… Read More

#News

Covid/neuroscience concept
#AI / data analytics / healthtech / informatics #Drug discovery #Neuroscience

DDW Spring issue out now

The Spring 2023 issue of Drug Discovery World Magazine is out now. Featuring a Therapeutic Spotlight on Neuroscience, the magazine is available to download free here and read for free on the DDW App. You can also request to receive a copy of the printed magazine here. Key features of the… Read More

#Editor's Choice #News

World Parkinson's Day
#Drug development #Drug discovery #Neurodegenerative disorders #Parkinson's

World Parkinson’s Day: New drug research

It is World Parkinson’s Day (11 April), raising awareness of the fastest growing neurological condition in the world. There is currently no cure, and although there are therapeutics to manage the symptoms, these usually bring side-effects, and so there is still need for new therapeutic options. Read More

#Exclusive Content #Trending News

#Cancer research #Clinical research #Clinical trial #Drug discovery #Oncology #Phase I trial #Phase II trial

Podcast shares industry highlights for 3-7 April

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The headlines this week have revealed a high level of clinical trial activity taking place… Read More

#News